Guyer D R, Yannuzzi L A, Slakter J S, Sorenson J A, Hope-Ross M, Orlock D R
Retinal Research Laboratory, Manhattan Eye, Ear & Throat Hospital, New York 10021.
Ophthalmology. 1994 Oct;101(10):1727-35; discussion 1735-7. doi: 10.1016/s0161-6420(13)31433-x.
Occult choroidal neovascularization (CNV) secondary to age-related macular degeneration occurs in the majority of patients with exudative maculopathy. Since occult CNV cannot be imaged clearly by fluorescein angiography, this condition is untreatable. The authors performed digital indocyanine-green videoangiography (ICG-V) on 657 consecutive eyes with occult CNV by fluorescein angiography to determine if this technique could be useful in enhancing the imaging of the neovascularization, and thus increasing treatment eligibility.
Six hundred fifty-seven consecutive eyes with occult CNV were studied. The fluorescein and ICG angiograms were compared, and the percentage of patients potentially eligible for laser therapy based on ICG findings was calculated.
Of 413 eyes with occult CNV without pigment epithelial detachments, focal areas of neovascularization were noted in 89 (22%). Overall, 142 (34.3%) eyes had lesions that were potentially treatable by laser photocoagulation based on additional information provided by ICG-V. Of the 235 eyes with occult CNV and vascularized pigment epithelial detachments, 98 (42%) were eligible for laser therapy based on ICG-V findings. The authors calculate that ICG-V enhances the treatment eligibility by approximately one third.
In diagnosing occult CNV, ICG-V is an important adjunctive technique to fluorescein angiography. This technique is especially useful in delineating occult neovascularization, neovascularization with overlying subretinal hemorrhage or serosanguineous fluid, and neovascularization associated with pigment epithelial detachments. The authors currently suggest that ICG-V be performed in eyes in which well-delineated neovascularization cannot be identified by fluorescein angiography. Based on their preliminary study, it can be expected that one in three patients with occult CNV potentially will be eligible for laser photocoagulation based on ICG-V. Further studies are necessary to confirm these findings.
大多数渗出性黄斑病变患者会出现年龄相关性黄斑变性继发的隐匿性脉络膜新生血管(CNV)。由于隐匿性CNV无法通过荧光素血管造影清晰成像,因此这种情况无法治疗。作者对657只经荧光素血管造影诊断为隐匿性CNV的连续病例进行了数字吲哚菁绿视频血管造影(ICG-V),以确定该技术是否有助于增强新生血管的成像,从而增加治疗的可能性。
对657只连续的隐匿性CNV患眼进行研究。比较荧光素血管造影和ICG血管造影,并根据ICG检查结果计算可能适合激光治疗的患者百分比。
在413只无色素上皮脱离的隐匿性CNV患眼中,89只(22%)发现有新生血管的局灶性区域。总体而言,根据ICG-V提供的额外信息,142只(34.3%)患眼的病变有可能通过激光光凝治疗。在235只伴有血管化色素上皮脱离的隐匿性CNV患眼中,98只(42%)根据ICG-V检查结果适合激光治疗。作者计算得出,ICG-V使治疗可能性提高了约三分之一。
在诊断隐匿性CNV时,ICG-V是荧光素血管造影的一项重要辅助技术。该技术在描绘隐匿性新生血管、伴有视网膜下出血或血清血液性液体的新生血管以及与色素上皮脱离相关的新生血管方面特别有用。作者目前建议,对于荧光素血管造影无法清晰识别新生血管的患眼,应进行ICG-V检查。根据他们的初步研究,预计三分之一的隐匿性CNV患者可能根据ICG-V适合激光光凝治疗。需要进一步研究来证实这些发现。